These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2099359)

  • 21. Polymorphic ability to metabolize propranolol alters 4-hydroxypropranolol levels but not beta blockade.
    Raghuram TC; Koshakji RP; Wilkinson GR; Wood AJ
    Clin Pharmacol Ther; 1984 Jul; 36(1):51-6. PubMed ID: 6734049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular responses to metipranolol and timolol eyedrops in healthy volunteers.
    Bacon PJ; Brazier DJ; Smith R; Smith SE
    Br J Clin Pharmacol; 1989 Jan; 27(1):1-5. PubMed ID: 2565117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of debrisoquine oxidation phenotype on exercise tolerance and subjective fatigue after metoprolol and atenolol in healthy subjects.
    Lewis RV; Ramsay LE; Jackson PR; Yeo WW; Lennard MS; Tucker GT
    Br J Clin Pharmacol; 1991 Apr; 31(4):391-8. PubMed ID: 2049246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A noninvasive tonometer in the measurement of the effects of pindolol and timolol on intraocular pressure in normal subjects.
    Rowley S; Staunton JE; Tosch A; Stewart-Jones JH; Edgar DF; Turner P
    Br J Ophthalmol; 1981 Aug; 65(8):536-8. PubMed ID: 7295615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of debrisoquine oxidation phenotypes in glaucoma patients.
    Salminen L; Lindberg R; Toivari HR; Huupponen R; Kaila T; Iisalo E
    Int Ophthalmol; 1989 Jan; 13(1-2):91-3. PubMed ID: 2787298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of beta-adrenoceptor antagonists and levomepromazine on the metabolic ratio of debrisoquine.
    Kallio J; Huupponen R; Seppälä M; Säkö E; Iisalo E
    Br J Clin Pharmacol; 1990 Oct; 30(4):638-43. PubMed ID: 1981321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Debrisoquine hydroxylation and sulfamethazine acetylation in a Chinese population.
    Xu XM; Jiang WD
    Zhongguo Yao Li Xue Bao; 1990 Sep; 11(5):385-8. PubMed ID: 2130590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-inheritance of the polymorphic metabolism of encainide and debrisoquin.
    Woosley RL; Roden DM; Dai GH; Wang T; Altenbern D; Oates J; Wilkinson GR
    Clin Pharmacol Ther; 1986 Mar; 39(3):282-7. PubMed ID: 3081292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphic metabolism of the beta-adrenoreceptor blocking drugs and its clinical relevance.
    Smith RL
    Eur J Clin Pharmacol; 1985; 28 Suppl():77-84. PubMed ID: 2865154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bronchial beta-adrenoceptor blockade following eyedrops of timolol and its isomer L-714,465 in normal subjects.
    Richards R; Tattersfield AE
    Br J Clin Pharmacol; 1985 Nov; 20(5):459-62. PubMed ID: 2866789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacokinetics of indoramin and 6-hydroxyindoramin in poor and extensive hydroxylators of debrisoquine.
    Pierce DM; Smith SE; Franklin RA
    Eur J Clin Pharmacol; 1987; 33(1):59-65. PubMed ID: 3691597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A population study of the poor metabolizers of the debrisoquine type in Japan].
    Hayashi M; Takase M
    Nippon Ganka Gakkai Zasshi; 1985 Aug; 89(8):983-90. PubMed ID: 4072846
    [No Abstract]   [Full Text] [Related]  

  • 33. Dopamine-2 receptor blockade does not affect the ocular hypotensive action of timolol.
    Mekki QA; Turner P
    Br J Ophthalmol; 1988 Aug; 72(8):598-600. PubMed ID: 3415954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of d-timolol on intraocular pressure in the normal subjects].
    Sugiyama K; Kawai K; Kitazawa Y
    Nippon Ganka Gakkai Zasshi; 1986 Jun; 90(6):866-70. PubMed ID: 3751788
    [No Abstract]   [Full Text] [Related]  

  • 35. Initial evaluation of transdermal timolol: serum concentrations and beta-blockade.
    Vlasses PH; Ribeiro LG; Rotmensch HH; Bondi JV; Loper AE; Hichens M; Dunlay MC; Ferguson RK
    J Cardiovasc Pharmacol; 1985; 7(2):245-50. PubMed ID: 2581075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of intravenous timolol in patients with acute myocardial infarction and in healthy volunteers.
    Vedin JA; Kristianson JK; Wilhelmsson CE
    Eur J Clin Pharmacol; 1982; 23(1):43-7. PubMed ID: 7128671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eyes or patients? Traps for the unwary in the statistical analysis of ophthalmological studies.
    Newcombe RG; Duff GR
    Br J Ophthalmol; 1987 Sep; 71(9):645-6. PubMed ID: 3663557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of moderate exercise on intraocular pressure.
    McDaniel DR; Tribbey CL; Tobias GS
    Am J Optom Physiol Opt; 1983 Mar; 60(3):154-7. PubMed ID: 6846492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of different intensities of exercise on intraocular pressure.
    Rowe DG; Teraslinna P; Kielar RA; Jackson JA
    Res Q; 1976 Oct; 47(3):436-44. PubMed ID: 1069333
    [No Abstract]   [Full Text] [Related]  

  • 40. Concentration of debrisoquine by human platelets in vivo: relationship to hypotensive effect [proceedings].
    Lennard MS; Silas JH; Smith AJ; Tucker GT
    Br J Clin Pharmacol; 1977 Oct; 4(5):635P. PubMed ID: 911620
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.